Sex differences and estrogen regulation of miRNAs in lupus, a prototypical autoimmune disease

Cellular Immunology

Volumn 294, Issue 2, 2015, Pages 70-79

  Khan, Deena ^a   Dai, Rujuan ^a   Ansar Ahmed, S ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

Autoimmune; Estrogen; Immune; Lupus; MicroRNA; Sex differences

Indexed keywords

ESTROGEN; MICRORNA;

ARTICLE; BIOGENESIS; CYTOPLASM; EPIGENETICS; GENE EXPRESSION; HEART FIBROBLAST; HUMAN; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; X CHROMOSOME; Y CHROMOSOME; ANIMAL; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MALE; METABOLISM; MOUSE; SEXUAL DEVELOPMENT;

MUS;

ANIMALS; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICRORNAS; SEX CHARACTERISTICS;

EID: 84930901482     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2015.01.004     Document Type: Article

References (143)

1. Progress in Autoimmune Diseases Research, Report to Congress, in: T.A.D.C. Committee (Ed.), National Institutes of Health, 2005.
2. Fairweather D., Frisancho-Kiss S., Rose N.R. Sex differences in autoimmune disease from a pathological perspective. Am. J. Pathol. 2008, 173:600-609.
3. AnsarAhmed S., Hissong B.D., Verthelyi D., Donner K., Becker K., Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: possible role of estrogenic compounds. Environ. Health Perspect. 1999, 107(Suppl 5):681-686.
4. Ansar Ahmed S., Penhale W.J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 1985, 121:531-551.
5. Whitacre C.C. Sex differences in autoimmune disease. Nat. Immunol. 2001, 2:777-780.
6. Lamason R., Zhao P., Rawat R., Davis A., Hall J.C., Chae J.J., Agarwal R., Cohen P., Rosen A., Hoffman E.P., Nagaraju K. Sexual dimorphism in immune response genes as a function of puberty. BMC Immunol. 2006, 7:2.
7. De Leon-Nava M.A., Nava K., Soldevila G., Lopez-Griego L., Chavez-Rios J.R., Vargas-Villavicencio J.A., Morales-Montor J. Immune sexual dimorphism: effect of gonadal steroids on the expression of cytokines, sex steroid receptors, and lymphocyte proliferation. J. Steroid Biochem. Mol. Biol. 2009, 113:57-64.
8. Moxley G., Posthuma D., Carlson P., Estrada E., Han J., Benson L.L., Neale M.C. Sexual dimorphism in innate immunity. Arthritis Rheum. 2002, 46:250-258.
9. Strickland F.M., Hewagama A., Lu Q., Wu A., Hinderer R., Webb R., Johnson K., Sawalha A.H., Delaney C., Yung R., Richardson B.C. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J. Autoimmun. 2012, 38:J135-143.
10. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J. Autoimmun. 2009, 33:12-16.
11. Libert C., Dejager L., Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat. Rev. Immunol. 2010, 10:594-604.
12. Klein S.L. Immune cells have sex and so should journal articles. Endocrinology 2012, 153:2544-2550.
13. S.L.a.R. C.W. Klein, Sex hormones and immunity to infection, in: S.L.a.R. C.W. Klein (Ed.), Springer-Verlag, Berlin, 2010.
14. Dai R., Ansar Ahmed S. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011, 157:163-179.
15. Dai R., Ansar Ahmed S. Sexual dimorphism of miRNA expression: a new perspective in understanding the sex bias of autoimmune diseases. Ther. Clin. Risk Manag. 2014, 10:151-163.
16. Brummer A., Hausser J. MicroRNA binding sites in the coding region of mRNAs: extending the repertoire of post-transcriptional gene regulation. BioEssays 2014, 36:617-626.
17. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
18. Engels B.M., Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006, 25:6163-6169.
19. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
20. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004, 32:D109-111.
21. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
22. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
23. Macfarlane L.A., Murphy P.R. MicroRNA: biogenesis, function and role in cancer. Curr. Genomics 2010, 11:537-561.
24. Lagos-Quintana M., Rauhut R., Meyer J., Borkhardt A., Tuschl T. New microRNAs from mouse and human. RNA 2003, 9:175-179.
25. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
26. Ying S.Y., Chang C.P., Lin S.L. Intron-mediated RNA interference, intronic microRNAs, and applications. Methods Mol. Biol. 2010, 629:205-237.
27. Ruby J.G., Jan C.H., Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 2007, 448:83-86.
28. Okamura K., Hagen J.W., Duan H., Tyler D.M., Lai E.C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 2007, 130:89-100.
29. Berezikov E., Chung W.J., Willis J., Cuppen E., Lai E.C. Mammalian mirtron genes. Mol. Cell 2007, 28:328-336.
30. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
31. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
32. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
33. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
34. Parker R., Song H. The enzymes and control of eukaryotic mRNA turnover. Nat. Struct. Mol. Biol. 2004, 11:121-127.
35. Coller J., Parker R. Eukaryotic mRNA decapping. Annu. Rev. Biochem. 2004, 73:861-890.
36. Bernstein E., Kim S.Y., Carmell M.A., Murchison E.P., Alcorn H., Li M.Z., Mills A.A., Elledge S.J., Anderson K.V., Hannon G.J. Dicer is essential for mouse development. Nat. Genet. 2003, 35:215-217.
37. Baltimore D., Boldin M.P., O'Connell R.M., Rao D.S., Taganov K.D. MicroRNAs: new regulators of immune cell development and function. Nat. Immunol. 2008, 9:839-845.
38. Zhang B., Pan X., Cobb G.P., Anderson T.A. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007, 302:1-12.
39. O'Connell R.M., Rao D.S., Chaudhuri A.A., Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10:111-122.
40. Krutzfeldt J., Stoffel M. MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab. 2006, 4:9-12.
41. Staedel C., Darfeuille F. MicroRNAs and bacterial infection. Cell. Microbiol. 2013, 15:1496-1507.
42. Cheung L., Gustavsson C., Norstedt G., Tollet-Egnell P. Sex-different and growth hormone-regulated expression of microRNA in rat liver. BMC Mol. Biol. 2009, 10:13.
43. Mujahid S., Logvinenko T., Volpe M.V., Nielsen H.C. MiRNA regulated pathways in late stage murine lung development. BMC Dev. Biol. 2013, 13:13.
44. Morgan C.P., Bale T.L. Sex differences in microRNA regulation of gene expression: no smoke, just miRs. Biol. Sex Differ. 2012, 3:22.
45. Pak T.R., Rao Y.S., Prins S.A., Mott N.N. An emerging role for microRNAs in sexually dimorphic neurobiological systems. Pflugers Arch. 2013, 465:655-667.
46. Ziats M.N., Rennert O.M. Identification of differentially expressed microRNAs across the developing human brain. Mol. Psychiatry 2013.
47. Morgan C.P., Bale T.L. Early prenatal stress epigenetically programs dysmasculinization in second-generation offspring via the paternal lineage. J. Neurosci. 2011, 31:11748-11755.
48. Koturbash I., Zemp F., Kolb B., Kovalchuk O. Sex-specific radiation-induced microRNAome responses in the hippocampus, cerebellum and frontal cortex in a mouse model. Mutat. Res. 2011, 722:114-118.
49. Raiche J., Rodriguez-Juarez R., Pogribny I., Kovalchuk O. Sex- and tissue-specific expression of maintenance and de novo DNA methyltransferases upon low dose X-irradiation in mice. Biochem. Biophys. Res. Commun. 2004, 325:39-47.
50. Mani S.T., Thakur M.K. In the cerebral cortex of female and male mice, amyloid precursor protein (APP) promoter methylation is higher in females and differentially regulated by sex steroids. Brain Res. 2006, 1067:43-47.
51. Murphy S.J., Lusardi T.A., Phillips J.I., Saugstad J.A. Sex differences in microRNA expression during development in rat cortex. Neurochem. Int. 2014.
52. Selvamani A., Williams M.H., Miranda R.C., Sohrabji F. Circulating miRNA profiles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model. Clin. Sci. 2014, 127:77-89.
53. Mellios N., Galdzicka M., Ginns E., Baker S.P., Rogaev E., Xu J., Akbarian S. Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr. Bull. 2012, 38:433-443.
54. Queiros A.M., Eschen C., Fliegner D., Kararigas G., Dworatzek E., Westphal C., Sanchez Ruderisch H., Regitz-Zagrosek V. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int. J. Cardiol. 2013, 169:331-338.
55. Wijchers P.J., Festenstein R.J. Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends Genet. 2011, 27:132-140.
56. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 2008, 8:737-744.
57. Pinheiro I., Dejager L., Libert C. X-chromosome-located microRNAs in immunity: might they explain male/female differences? The X chromosome-genomic context may affect X-located miRNAs and downstream signaling, thereby contributing to the enhanced immune response of females. BioEssays 2011, 33:791-802.
58. Hewagama A. Role of X-chromosome encoded miRNAs in autoimmunity: suppressing the suppressor and female predisposition. Rheumatol. Curr. Res. 2013, 3:118.
59. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
60. Johnnidis J.B., Harris M.H., Wheeler R.T., Stehling-Sun S., Lam M.H., Kirak O., Brummelkamp T.R., Fleming M.D., Camargo F.D. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008, 451:1125-1129.
61. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Muller-Tidow C., Bohlander S.K., Tenen D.G., Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
62. Stamatopoulos B., Meuleman N., Haibe-Kains B., Saussoy P., Van Den Neste E., Michaux L., Heimann P., Martiat P., Bron D., Lagneaux L. MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood 2009, 113:5237-5245.
63. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F., Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008, 135:257-269.
64. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., Colombo T., Citarella F., Barnaba V., Minisola G., Galeazzi M., Macino G. MiR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum. Immunol. 2010, 71:206-211.
65. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc. Res. 2010, 86:410-420.
66. Wang H., Peng W., Ouyang X., Li W., Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl. Res. 2012, 160:198-206.
67. Pandis I., Ospelt C., Karagianni N., Denis M.C., Reczko M., Camps C., Hatzigeorgiou A.G., Ragoussis J., Gay S., Kollias G. Identification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model. Ann. Rheum. Dis. 2012, 71:1716-1723.
68. Lu C., Huang X., Zhang X., Roensch K., Cao Q., Nakayama K.I., Blazar B.R., Zeng Y., Zhou X. MiR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 2011, 117:4293-4303.
69. Grigoryev Y.A., Kurian S.M., Hart T., Nakorchevsky A.A., Chen C., Campbell D., Head S.R., Yates J.R., Salomon D.R. MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J. Immunol. 2011, 187:2233-2243.
70. Liu Y., Chen Q., Song Y., Lai L., Wang J., Yu H., Cao X., Wang Q. MicroRNA-98 negatively regulates IL-10 production and endotoxin tolerance in macrophages after LPS stimulation. FEBS Lett. 2011, 585:1963-1968.
71. Yang Z., Wang L. Regulation of microRNA expression and function by nuclear receptor signaling. Cell Biosci. 2011, 1:31.
72. Bhat-Nakshatri P., Wang G., Collins N.R., Thomson M.J., Geistlinger T.R., Carroll J.S., Brown M., Hammond S., Srour E.F., Liu Y., Nakshatri H. Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res. 2009, 37:4850-4861.
73. Castellano L., Giamas G., Jacob J., Coombes R.C., Lucchesi W., Thiruchelvam P., Barton G., Jiao L.R., Wait R., Waxman J., Hannon G.J., Stebbing J. The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15732-15737.
74. Klinge C.M. MiRNAs and estrogen action. Trends Endocrinol. 2012, 23:223-233.
75. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19:833-842.
76. Khan D., Cawan C., Ansar Ahmed S. Estrogen and signaling in the cells of immune system. Adv. Neuroimmune Biol. 2012, 3:73-93.
77. Paris O., Ferraro L., Grober O.M., Ravo M., De Filippo M.R., Giurato G., Nassa G., Tarallo R., Cantarella C., Rizzo F., Di Benedetto A., Mottolese M., Benes V., Ambrosino C., Nola E., Weisz A. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 2012, 31:4196-4206.
78. Klinge C.M. Estrogen regulation of microRNA expression. Curr. Genomics 2009, 10:169-183.
79. Saumet A., Vetter G., Bouttier M., Antoine E., Roubert C., Orsetti B., Theillet C., Lecellier C.H. Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells. Mol. BioSyst. 2012, 8:3242-3253.
80. Dai R., Phillips R.A., Zhang Y., Khan D., Crasta O., Ansar Ahmed S. Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 2008, 112:4591-4597.
81. Di Leva G., Gasparini P., Piovan C., Ngankeu A., Garofalo M., Taccioli C., Iorio M.V., Li M., Volinia S., Alder H., Nakamura T., Nuovo G., Liu Y., Nephew K.P., Croce C.M. MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J. Natl. Cancer Inst. 2010, 102:706-721.
82. Shi Z., Zhao C., Guo X., Ding H., Cui Y., Shen R., Liu J. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERalpha expression in estrogen-induced insulin resistance. Endocrinology 2014, 155:1982-1990.
83. Nothnick W.B., Healy C., Hong X. Steroidal regulation of uterine miRNAs is associated with modulation of the miRNA biogenesis components Exportin-5 and Dicer1. Endocrine 2010, 37:265-273.
84. Cheng C., Fu X., Alves P., Gerstein M. MRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer. Genome Biol. 2009, 10:R90.
85. Yamagata K., Fujiyama S., Ito S., Ueda T., Murata T., Naitou M., Takeyama K., Minami Y., O'Malley B.W., Kato S. Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol. Cell 2009, 36:340-347.
86. Olivieri F., Ahtiainen M., Lazzarini R., Pollanen E., Capri M., Lorenzi M., Fulgenzi G., Albertini M.C., Salvioli S., Alen M.J., Kujala U.M., Borghetti G., Babini L., Kaprio J., Sipila S., Franceschi C., Kovanen V., Procopio A.D. Hormone replacement therapy enhances IGF-1 signaling in skeletal muscle by diminishing miR-182 and miR-233 expressions: a study on postmenopausal monozygotic twin pairs. Aging Cell 2014.
87. Tao S., He H., Chen Q., Yue W. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer. Biochem. Biophys. Res. Commun. 2014.
88. Cervera R., Doria A., Amoura Z., Khamashta M., Schneider M., Guillemin F., Maurel F., Garofano A., Roset M., Perna A., Murray M., Schmitt C., Boucot I. Patterns of systemic lupus erythematosus expression in Europe. Autoimmun. Rev. 2014, 13:621-629.
89. Urowitz M.B., Gladman D.D., Ibanez D., Fortin P.R., Bae S.C., Gordon C., Clarke A., Bernatsky S., Hanly J.G., Isenberg D., Rahman A., Sanchez-Guerrero J., Wallace D.J., Ginzler E., Alarcon G.S., Merrill J.T., Bruce I.N., Sturfelt G., Nived O., Steinsson K., Khamashta M., Petri M., Manzi S., Ramsey-Goldman R., Dooley M.A., van Vollenhoven R.F., Ramos M., Stoll T., Zoma A., Kalunian K., Aranow C. Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort. Arthritis Care Res. 2012, 64:132-137.
90. Invernizzi P. The X chromosome in female-predominant autoimmune diseases. Ann. N. Y. Acad. Sci. 2007, 1110:57-64.
91. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., Akarsu N., Toruner G., Kamel N., Gullu S. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur. J. Hum. Genet. 2006, 14:791-797.
92. Quintero O.L., Amador-Patarroyo M.J., Montoya-Ortiz G., Rojas-Villarraga A., Anaya J.M. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J. Autoimmun. 2012, 38:J109-119.
93. Ansar Ahmed S., Karpuzoglu E., Khan D. Effects of sex steroids on innate and adaptive immunity. Sex Hormones and Immunity to Infection 2010, 53-92. Springer.
94. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28:521-574.
95. Kassi E., Moutsatsou P. Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 2010:317452.
96. Sekigawa I., Fujishiro M., Yamaguchi A., Kawasaki M., Inui A., Nozawa K., Takasaki Y., Takamori K., Ogawa H. A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus. Clin. Exp. Rheumatol. 2010, 28:419-423.
97. Walker S.E. Estrogen and autoimmune disease. Clin. Rev. Allergy Immunol. 2011, 40:60-65.
98. Ahmed S.A., Talal N. Sex hormones and the immune system - Part 2. Animal data. Bailliere's Clin. Rheumatol. 1990, 4:13-31.
99. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J. Allergy Clin. Immunol. 1999, 103:282-288.
100. Durali D., de Goer de Herve M.G., Giron-Michel J., Azzarone B., Delfraissy J.F., Taoufik Y. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 2003, 102:4084-4089.
101. Sekigawa I., Naito T., Hira K., Mitsuishi K., Ogasawara H., Hashimoto H., Ogawa H. Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy. Lupus 2004, 13:217-222.
102. Venkatesh J., Yoshifuji H., Kawabata D., Chinnasamy P., Stanevsky A., Grimaldi C.M., Cohen-Solal J., Diamond B. Antigen is required for maturation and activation of pathogenic anti-DNA antibodies and systemic inflammation. J. Immunol. 2011, 186:5304-5312.
103. Roubinian J., Talal N., Siiteri P.K., Sadakian J.A. Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 1979, 22:1162-1169.
104. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 1978, 147:1568-1583.
105. Cui Y., Sheng Y., Zhang X. Genetic susceptibility to SLE: recent progress from GWAS. J. Autoimmun. 2013, 41:25-33.
106. Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D., Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S., Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S., Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R., Glockner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D., Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H., McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Muller I., Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'Dell C.N., Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K., Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D., Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R., Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A., Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F., Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L., Weinstock G., Sulston J.E., Durbin R., Hubbard T., Gibbs R.A., Beck S., Rogers J., Bentley D.R. The DNA sequence of the human X chromosome. Nature 2005, 434:325-337.
107. Carrel L., Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005, 434:400-404.
108. Garcia-Ortiz H., Velazquez-Cruz R., Espinosa-Rosales F., Jimenez-Morales S., Baca V., Orozco L. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann. Rheum. Dis. 2010, 69:1861-1865.
109. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., Wu Y.L., Yu C.Y., Tang Y., Chen J.Y., Yang W., Wong M., Kawasaki A., Tsuchiya N., Sumida T., Kawaguchi Y., Howe H.S., Mok M.Y., Bang S.Y., Liu F.L., Chang D.M., Takasaki Y., Hashimoto H., Harley J.B., Guthridge J.M., Grossman J.M., Cantor R.M., Song Y.W., Bae S.C., Chen S., Hahn B.H., Lau Y.L., Tsao B.P. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15838-15843.
110. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 2007, 179:6352-6358.
111. Laffont S., Rouquie N., Azar P., Seillet C., Plumas J., Aspord C., Guery J.C. X-Chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-alpha production of plasmacytoid dendritic cells from women. J. Immunol. 2014.
112. Dai R., Zhang Y., Khan D., Heid B., Caudell D., Crasta O., Ansar Ahmed S. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One 2010, 5:e14302.
113. Shen N., Liang D., Tang Y., de Vries N., Tak P.P. MicroRNAs - novel regulators of systemic lupus erythematosus pathogenesis. Nat. Rev. Rheumatol. 2012, 8:701-709.
114. Alevizos I., Illei G.G. MicroRNAs in Sjogren's syndrome as a prototypic autoimmune disease. Autoimmun. Rev. 2010, 9:618-621.
115. Ceribelli A., Yao B., Dominguez-Gutierrez P.R., Nahid M.A., Satoh M., Chan E.K. MicroRNAs in systemic rheumatic diseases. Arthritis Res. Ther. 2011, 13:229.
116. Du C., Liu C., Kang J., Zhao G., Ye Z., Huang S., Li Z., Wu Z., Pei G. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10:1252-1259.
117. Ode F., Moore C.S., Kennedy T.E., Antel J.P., Bar-Or A., Dhaunchak A.S. MicroRNA dysregulation in multiple sclerosis. Front. Genet. 2012, 3:311.
118. Carlsen A.L., Schetter A.J., Nielsen C.T., Lood C., Knudsen S., Voss A., Harris C.C., Hellmark T., Segelmark M., Jacobsen S., Bengtsson A.A., Heegaard N.H. Circulating microRNA expression profiles associated with systemic lupus erythematosus. Arthritis Rheum. 2013, 65:1324-1334.
119. Wang G., Tam L.S., Li E.K., Kwan B.C., Chow K.M., Luk C.C., Li P.K., Szeto C.C. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus 2011, 20:493-500.
120. Stagakis E., Bertsias G., Verginis P., Nakou M., Hatziapostolou M., Kritikos H., Iliopoulos D., Boumpas D.T. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann. Rheum. Dis. 2011, 70:1496-1506.
121. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., Li J., Zhou H., Tang Y., Shen N. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J. Immunol. 2010, 184:6773-6781.
122. Qin H., Zhu X., Liang J., Wu J., Yang Y., Wang S., Shi W., Xu J. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1. J. Dermatol. Sci. 2013, 69:61-67.
123. Qin H.H., Zhu X.H., Liang J., Yang Y.S., Wang S.S., Shi W.M., Xu J.H. Associations between aberrant DNA methylation and transcript levels of DNMT1 and MBD2 in CD4+T cells from patients with systemic lupus erythematosus. Australas. J. Dermatol. 2013, 54:90-95.
124. Zhao S., Wang Y., Liang Y., Zhao M., Long H., Ding S., Yin H., Lu Q. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 2011, 63:1376-1386.
125. Hai-yan W., Yang L., Mei-hong C., Hui Z. Expression of MicroRNA-146a in peripheral blood mononuclear cells in patients with systemic lupus Erythematosus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2011, 33:185-188.
126. Zhao X., Tang Y., Qu B., Cui H., Wang S., Wang L., Luo X., Huang X., Li J., Chen S., Shen N. MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010, 62:3425-3435.
127. Ding S., Liang Y., Zhao M., Liang G., Long H., Zhao S., Wang Y., Yin H., Zhang P., Zhang Q., Lu Q. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. Arthritis Rheum. 2012, 64:2953-2963.
128. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., Huang X., Zhou H., de Vries N., Tak P.P., Chen S., Shen N. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum. 2009, 60:1065-1075.
129. Dai R., McReynolds S., Leroith T., Heid B., Liang Z., Ansar Ahmed S. Sex differences in the expression of lupus-associated miRNAs in splenocytes from lupus-prone NZB/WF1 mice. Biol. Sex Differ. 2013, 4:19.
130. Shi H., Zheng L.Y., Zhang P., Yu C.Q. MiR-146a and miR-155 expression in PBMCs from patients with Sjogren's syndrome. J. Oral Pathol. Med. 2014.
131. O'Connell R.M., Kahn D., Gibson W.S., Round J.L., Scholz R.L., Chaudhuri A.A., Kahn M.E., Rao D.S., Baltimore D. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 2010, 33:607-619.
132. Kurowska-Stolarska M., Alivernini S., Ballantine L.E., Asquith D.L., Millar N.L., Gilchrist D.S., Reilly J., Ierna M., Fraser A.R., Stolarski B., McSharry C., Hueber A.J., Baxter D., Hunter J., Gay S., Liew F.Y., McInnes I.B. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11193-11198.
133. Leng R.X., Pan H.F., Qin W.Z., Chen G.M., Ye D.Q. Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev. 2011, 22:141-147.
134. Divekar A.A., Dubey S., Gangalum P.R., Singh R.R. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J. Immunol. 2011, 186:924-930.
135. Fan W., Liang D., Tang Y., Qu B., Cui H., Luo X., Huang X., Chen S., Higgs B.W., Jallal B., Yao Y., Harley J.B., Shen N. Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus. Arthritis Rheum. 2012, 64:3715-3725.
136. Helms W.S., Jeffrey J.L., Holmes D.A., Townsend M.B., Clipstone N.A., Su L. Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells. J. Leukoc. Biol. 2007, 82:361-369.
137. Xue F., Li H., Zhang J., Lu J., Xia Y., Xia Q. MiR-31 regulates interleukin 2 and kinase suppressor of ras 2 during T cell activation. Genes Immun. 2013, 14:127-131.
138. Rouas R., Fayyad-Kazan H., El Zein N., Lewalle P., Rothe F., Simion A., Akl H., Mourtada M., El Rifai M., Burny A., Romero P., Martiat P., Badran B. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 2009, 39:1608-1618.
139. Stittrich A.B., Haftmann C., Sgouroudis E., Kuhl A.A., Hegazy A.N., Panse I., Riedel R., Flossdorf M., Dong J., Fuhrmann F., Heinz G.A., Fang Z., Li N., Bissels U., Hatam F., Jahn A., Hammoud B., Matz M., Schulze F.M., Baumgrass R., Bosio A., Mollenkopf H.J., Grun J., Thiel A., Chen W., Hofer T., Loddenkemper C., Lohning M., Chang H.D., Rajewsky N., Radbruch A., Mashreghi M.F. The microRNA miR-182 is induced by IL-2 and promotes clonal expansion of activated helper T lymphocytes. Nat. Immunol. 2010, 11:1057-1062.
140. Yang W.B., Chen P.H., Hsu T.s., Fu T.F., Su W.C., Liaw H., Chang W.C., Hung J.J. Sp1-mediated microRNA-182 expression regulates lung cancer progression. Oncotarget 2014, 5:740-753.
141. Xie T., Liang J., Liu N., Wang Q., Li Y., Noble P.W., Jiang D. MicroRNA-127 inhibits lung inflammation by targeting IgG Fcgamma receptor I. J. Immunol. 2012, 188:2437-2444.
142. Onnis A., Navari M., Antonicelli G., Morettini F., Mannucci S., De Falco G., Vigorito E., Leoncini L. Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma. Blood Cancer J. 2012, 2:e84.
143. Hewagama A., Gorelik G., Patel D., Liyanarachchi P., McCune W.J., Somers E., Gonzalez-Rivera T., Strickland F., Richardson B. Overexpression of X-linked genes in T cells from women with lupus. J. Autoimmun. 2013, 41:60-71.